Collaboration between LAG-3 and PD-1 promotes cancer cell immune evasion and obstructing both LAG-3 and PD-1 is considerably more effective and less harmful for treating solid tumors that are advanced or have metastasized (20, 22). The gene discussed is LAG3; the disease is cancer.